期刊文献+

Subretinal fibrosis secondary to neovascular age-related macular degeneration:mechanisms and potential therapeutic targets

在线阅读 下载PDF
导出
摘要 Subretinal fibrosis is the end-stage sequelae of neovascular age-related macular degeneration.It causes local damage to photoreceptors,retinal pigment epithelium,and choroidal vessels,which leads to permanent central vision loss of patients with neovascular age-related macular degeneration.The pathogenesis of subretinal fibrosis is complex,and the underlying mechanisms are largely unknown.Therefore,there are no effective treatment options.A thorough understanding of the pathogenesis of subretinal fibrosis and its related mechanisms is important to elucidate its complications and explore potential treatments.The current article reviews several aspects of subretinal fibrosis,including the current understanding on the relationship between neovascular age-related macular degeneration and subretinal fibrosis;multimodal imaging techniques for subretinal fibrosis;animal models for studying subretinal fibrosis;cellular and non-cellular constituents of subretinal fibrosis;pathophysiological mechanisms involved in subretinal fibrosis,such as aging,infiltration of macrophages,different sources of mesenchymal transition to myofibroblast,and activation of complement system and immune cells;and several key molecules and signaling pathways participating in the pathogenesis of subretinal fibrosis,such as vascular endothelial growth factor,connective tissue growth factor,fibroblast growth factor 2,platelet-derived growth factor and platelet-derived growth factor receptor-β,transforming growth factor-βsignaling pathway,Wnt signaling pathway,and the axis of heat shock protein 70-Toll-like receptors 2/4-interleukin-10.This review will improve the understanding of the pathogenesis of subretinal fibrosis,allow the discovery of molecular targets,and explore potential treatments for the management of subretinal fibrosis.
出处 《Neural Regeneration Research》 SCIE CAS 2025年第2期378-393,共16页 中国神经再生研究(英文版)
基金 supported by grants from National Key R&D Program of China,No.2023YFC2506100(to JZ) the National Natural Science Foundation of China,No.82171062(to JZ).
  • 相关文献

参考文献8

二级参考文献30

  • 1Leask A;Abraham D J.TGF-beta signaling and the fibrotic response,2004(07).
  • 2Blobe GC,Schiemann WP.Lodish HF Role of transforming growth factor beta in human disease. The New England Journal of Medicine . 2000
  • 3Wynn TA.Cellular and molecular mechanisms of fibrosis. Journal of Paleopathology . 2008
  • 4Connor TB Jr,Roberts AB,Sporn MB,et al.Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. Journal of Clinical Investigation, The . 1989
  • 5DF Martin,MG Maguire,GS Ying,JE Grunwald,SL Fine,GJ Jaffe.Ranibizumab and bevacizumab for neovascular age-related macular degeneration. The New England Journal of Medicine . 2011
  • 6Rosenfeld PJ,Brown DM,Heier JS,Boyer DS,Kaiser PK,Chung CY,Kim RY.Ranibizumab for neovascular age-related macular degeneration. New England Journal of Medicine, The . 2006
  • 7Bian Z M,Elner S G,Elner V M.Regulation of VEGF mRNA ex-pression and protein secretion by TGF-beta2 in human retinal pigmentepithelial cells. Experimental Eye Research . 2007
  • 8Forrester JV,Lumsden L,Liversidge J,et al.Immunoregulation of uveoretinal inflammation. Progress in Retinal and Eye Research . 1995
  • 9Varga J,Pasche B.Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol . 2009
  • 10Massague J.TGF-β signal transduction. Annual Review of Biochemistry . 1998

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部